Risk factor
Strong trading liquidity
Profitability factor
Very strong margins and returns
About
Shenzhen New Industries Biomedical Engineering Co., Ltd., established in 1995 and headquartered in Shenzhen, China, operates as a prominent biomedical enterprise. This company focuses on the innovation, manufacturing, and commercialization of sophisticated clinical laboratory equipment and in-vitro diagnostic solutions. Its comprehensive portfolio, delivered to hospitals and research laboratories both within China and globally, encompasses various systems for immunology and clinical chemistry, integrated diagnostic platforms, and a full range of corresponding immunoassay and clinical chemistry reagent kits.
Company Valuation
Considering past and projected metrics, the stock is moderately 'expensive' compared to its peers. In particular, the stock is reasonably priced on P/E, of fair value on
Target Price
The average target price of 300832.SZ is 67 and suggests 53% upside potential. Usually, this means a BUY recommendation among investment firms, or a recommendation to inc